Hualan Vaccine ( 301207 ) On February 28, the number of shareholder accounts was 26,800, a decrease of 0.84% compared to the previous period.

According to Securities Star, recently Hualan Biological Engineering disclosed that as of February 28, 2026, the number of company shareholders was 26,800, a decrease of 227.0 from February 13, representing a reduction of 0.84%. The average number of shares held per account increased from 22,300 shares in the previous period to 22,400 shares, with an average market value of 464,700 yuan.

Among individual stocks in the biopharmaceutical industry, the number of Hualan Biological shareholders is below the industry average level. As of February 28, the average number of shareholders in the biopharmaceutical industry was 34,800. In terms of average market value of shares held per account, A-share listed companies in the biopharmaceutical industry had an average market value of 454,500 yuan, while Hualan Biological is above the industry average.

From the perspective of stock price, Hualan Biological experienced a price drop of 1.33% from February 13, 2026, to February 28, 2026, during which the number of shareholders decreased by 227.0, a reduction of 0.84%.

According to statistics, from February 13, 2026, to February 28, 2026, Hualan Biological had a net outflow of 48,268,000 yuan from main capital, a net inflow of 3,709,800 yuan from speculative funds, and a net inflow of 44,558,200 yuan from retail investors.

The above content is organized by Securities Star based on public information and generated by AI algorithms (Internet Information Filing No. 310104345710301240019), and does not constitute investment advice.